Management of toxicities associated with bortezomib.
Lonial
Sagar
S
Translational Research B-cell Malignancy Program, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D064420:Drug-Related Side Effects and Adverse Reactions / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000628:therapy; D009367:Neoplasm Staging; D036102:Peripheral Blood Stem Cell Transplantation; D011719:Pyrazines / Q000009:adverse effects*; D016896:Treatment Outcome
D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib